T-wave alternans for risk stratification and prevention of sudden cardiac death

Area of Science:

• Cardiology
• Electrophysiology
• Biomedical Engineering

Background:

• Ischemic heart disease management has advanced, yet life-threatening arrhythmias persist.
• Implantable cardioverter defibrillators (ICDs) reduce sudden cardiac death in reduced ejection fraction patients but lead to many unnecessary implants.
• T-wave alternans (TWA) reflects cellular repolarization alternations, increasing repolarization dispersion and risk for reentrant arrhythmias.

Purpose of the Study:

• To evaluate T-wave alternans (TWA) analysis as a noninvasive tool for identifying patients at risk of sudden cardiac death.
• To assess the potential of TWA to guide implantable cardioverter defibrillator (ICD) therapy decisions and reduce unnecessary procedures.

Main Methods:

• Analysis of T-wave alternans (TWA) in patients, drawing on data from recent trials involving nearly 3000 individuals.
• Evaluation of TWA's negative predictive value for arrhythmia events.

Main Results:

• TWA analysis has been established as a powerful tool for arrhythmia prevention in recent trials.
• An estimated one-third of post-myocardial infarction patients are expected to test negative for TWA.
• TWA demonstrates a negative predictive value greater than 90%, effectively identifying patients unlikely to benefit from ICDs.

Conclusions:

• Noninvasive T-wave alternans (TWA) testing can accurately identify high-risk patients for sudden cardiac death.
• TWA analysis may enable targeted ICD implantation, improving cost-effectiveness and reducing unnecessary procedures.
• Widespread TWA screening could enhance sudden death prevention strategies in broader populations.